Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The New England Journal of Medicine|October 15, 1987
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndromeC J Allegra, B A Chabner, C U Tuazon, et al.
The New England Journal of Medicine|January 9, 1992
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials GroupM S Saag, W G Powderly, G A Cloud, et al.
The Journal of Infectious Diseases|June 1, 1995
A modified ELISA and western blot accurately determine anti-human immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting deviceW W Emmons, S F Paparello, C F Decker, et al.
International Journal of STD & AIDS|March 17, 2012
Longitudinal assessment of cardiac diastolic function in HIV-infected patientsJ M Blaylock, D K Byers, B T Gibbs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 1999
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study GroupM S Saag, G A Cloud, J R Graybill, et al.
The New England Journal of Medicine|March 16, 2000
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosisD A Stevens, H J Schwartz, J Y Lee, et al.
The New England Journal of Medicine|July 3, 1997
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials GroupC M van der Horst, M S Saag, G A Cloud, et al.
The Journal of Infectious Diseases|May 1, 1996
Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activityD R Skillman, J L Malone, C F Decker, et al.
Pageof 9